News & Updates

The 5-HT_2A receptor agonist psilocybin, when taken under medical supervision, may offer a promising approach to treatment of major depressive disorder (MDD) in cancer patients, results of a small phase II study suggest.

Patients with alopecia areata (AA) are more susceptible to both anxiety and depression, according to the results of a systematic review and meta-analysis.

A study in India has shown the effectiveness of a small cash transfer in alleviating short-term functional impairment among older people who are living alone. However, cash transfers do not produce a clinically or statistically significant decrease in depression and show no impact on food security.

In Singapore, diagnostic radiographers were able to cope with the high demands of the COVID-19 pandemic in terms of provision of information, supplies, and physical equipment, a survey shows. However, they were less prepared to manage human factors, such as mental health and staff morale.

Successful management of depression through psychological therapies may be associated with a reduced risk of cardiovascular disease (CVD), a study has shown.

Children born to mothers who had depression and/or anxiety during pregnancy appear to have a heightened risk of developing type 1 diabetes, as shown in a study.

Dietary markers, such as animal protein intake, appear to contribute to depression and anxiety in individuals with comorbid obesity, reveals a study.

Familial depression is associated with lower cognitive performance in offspring, a cohort study has shown.

For cancer patients with depression, treatment with a single dose of psilocybin appears to yield rapid and meaningful improvements in depressive symptoms, as shown in a phase II study.